• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[探讨博鳌乐城先行区真实世界数据在医疗器械上市前临床评价中的应用]

[Discuss Application of Real-world Data from the Boao Lecheng Pilot Zone to Support Premarket Clinical Evaluation of Medical Device].

作者信息

Cai Lixian, Chang Limei, Li Yaohua, Zhu Ming, Zhang Hui

机构信息

Hainan Center for Drug and Medical Device Evaluation and Service, Haikou, 570216.

Center for Medical Device Evaluation, NMPA, Beijing, 100081.

出版信息

Zhongguo Yi Liao Qi Xie Za Zhi. 2023 Jan 30;47(1):83-88. doi: 10.3969/j.issn.1671-7104.2023.01.015.

DOI:10.3969/j.issn.1671-7104.2023.01.015
PMID:36752013
Abstract

The real-world data of Hainan Boao Lecheng International Tourism Pilot Zone has the advantage of supporting pre-market clinical evaluation of medical devices. Based on the relevant requirements of clinical evaluation of medical devices and based on the practical experience of pilot devices in the early stage, the application of Boao Lecheng real-world data in the pre-market clinical evaluation path of medical devices from the perspective of review is discussed. At the same time, the elements that should be considered in real-world study design and the way of data quality evaluation are proposed. Expect to provide a reference in order to allow registration applicants to use real world data wisely to help declare device registration for marketing.

摘要

海南博鳌乐城国际医疗旅游先行区的真实世界数据具有支持医疗器械上市前临床评价的优势。基于医疗器械临床评价的相关要求,结合前期试点器械的实践经验,从审评角度探讨博鳌乐城真实世界数据在医疗器械上市前临床评价路径中的应用。同时,提出真实世界研究设计中应考虑的要素及数据质量评价方式。期望提供参考,以便注册申请人合理运用真实世界数据,助力医疗器械上市注册申报。

相似文献

1
[Discuss Application of Real-world Data from the Boao Lecheng Pilot Zone to Support Premarket Clinical Evaluation of Medical Device].[探讨博鳌乐城先行区真实世界数据在医疗器械上市前临床评价中的应用]
Zhongguo Yi Liao Qi Xie Za Zhi. 2023 Jan 30;47(1):83-88. doi: 10.3969/j.issn.1671-7104.2023.01.015.
2
Use of real-world evidence to support regulatory decisions on medical devices in China and a unique opportunity to gain accelerated approval in "Boao Lecheng Pilot Zone".利用真实世界证据支持中国医疗器械监管决策以及在“博鳌乐城先行区”获得加速批准的独特机遇。
Cost Eff Resour Alloc. 2023 Jan 18;21(1):7. doi: 10.1186/s12962-022-00412-w.
3
[Real-world data studies of medical products in the context of special healthcare policy: study designs and key considerations].[特殊医疗政策背景下医疗产品的真实世界数据研究:研究设计与关键考量]
Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Jul 10;42(7):1306-1311. doi: 10.3760/cma.j.cn112338-20210201-00085.
4
Assessing the Risks of China's Medical Tourism from the Legal Perspective.从法律视角评估中国医疗旅游的风险
Risk Manag Healthc Policy. 2020 Oct 28;13:2291-2299. doi: 10.2147/RMHP.S271224. eCollection 2020.
5
[Preliminary Review of Relationship between Medical Device Evaluation and Quality Management System in Premarket Approval].
Zhongguo Yi Liao Qi Xie Za Zhi. 2020 Dec 8;44(6):532-536. doi: 10.3969/j.issn.1671-7104.2020.06.013.
6
Good statistical practice in utilizing real-world data in a comparative study for premarket evaluation of medical devices.在医疗器械上市前评估的比较研究中使用真实世界数据的良好统计实践。
J Biopharm Stat. 2019;29(4):580-591. doi: 10.1080/10543406.2019.1632880. Epub 2019 Jun 29.
7
Utilizing national and international registries to enhance pre-market medical device regulatory evaluation.利用国家和国际注册系统加强上市前医疗器械监管评估。
J Biopharm Stat. 2016;26(6):1136-1145. doi: 10.1080/10543406.2016.1226336. Epub 2016 Aug 19.
8
Characteristics of Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving FDA Premarket Approval in 2010 and 2011.2010 年和 2011 年 FDA 上市前批准的高风险治疗性医疗器械全产品生命周期临床试验特点。
JAMA. 2015 Aug 11;314(6):604-12. doi: 10.1001/jama.2015.8761.
9
Use of Real-World Evidence for Regulatory Approval and Coverage of Medical Devices: A Landscape Assessment.利用真实世界证据进行医疗器械的监管批准和覆盖范围评估:景观评估。
Value Health. 2021 Dec;24(12):1792-1798. doi: 10.1016/j.jval.2021.07.003. Epub 2021 Aug 18.
10
Regulatory issues relating to therapies for periodontal regeneration.与牙周再生治疗相关的监管问题。
Ann Periodontol. 1997 Mar;2(1):223-8. doi: 10.1902/annals.1997.2.1.223.